Indian healthcare startup PharmEasy to acquire majority stake in listed firm Thyrocare for over $600 million

API Holdings, which operates the giant healthcare startup PharmEasy, said on Friday it has reached an agreement to acquire 66.1% stake in Thyrocare, which runs a diagnostic lab chain, for about $613 million in what is the first ever acquisition of a listed firm by an unicorn startup.

The transaction is subject to regulatory and other applicable customary approvals. Docon Technologies Pvt Ltd, a 100% subsidiary of API, will be the acquirer and shall make an open offer for an additional 26% stake, the firm said in a statement.

“We are delighted to be partnering Thyrocare. We will provide world class customer experience in diagnostics, rivalling our pharmacy experience by leveraging technology, and building on top of the massive scale & truly pan-India presence of Thyrocare. It is our aim to deliver all outpatient healthcare products & services to every Indian within 24 hours,” Siddharth Shah, CEO of API Holdings, said in a statement.

This is a developing story. More to follow…

Credit belongs to : www.techcrunch.com

You May Also Like

Indian online insurer PolicyBazaar files for IPO, seeks to raise over $800 million

Indian online insurance aggregator PolicyBazaar has filed for an initial public offering in which it is seeking to raise $809 million, becoming the fourth startup in the past two months from the South Asian market to explore public markets. In papers submitted to the market regulator in India, PolicyBazaar said it is looking to raise […]

Indian edtech Unacademy valued at $3.44 billion in $440 million fundraise

Indian online learning platform Unacademy has raised $440 million in a new financing round as investors double down on the South Asian market and elsewhere following a widening series of regulatory crackdowns in China that wiped hundreds of billions of dollars last month. Temasek led the Bangalore-based startup’s new financing round — Series H — […]
error: Content is protected !!